Binsen Li, Ph.D.

Dr. Binsen Li is a Senior Associate at MPM BioImpact and is responsible for investment identification, due diligence and company creation opportunities in the APAC region.

Prior to joining MPM BioImpact, Binsen spent five years at Hillhouse Capital in New York, where he covered global healthcare investments across both the private and public markets. He was responsible for evaluating opportunities through diligence, building financial models, and crafting investment theses grounded in scientific and commercial insight.

Binsen earned his Ph.D. in Biochemistry, Molecular and Structural Biology from the University of California, Los Angeles. His doctoral research focused on amyloid fibrils in Parkinson’s disease using cryo-electron microscopy to inform structure-based therapeutic development. Earlier in his career, Binsen conducted neurobiology research at Harvard Medical School and received his B.A. in Biochemistry, Cellular and Molecular Biology from Connecticut College.

Outside of work, Binsen enjoys running and spending time outdoors with his wife and their tricolor Australian Shepherd, Mocha.